Response assessment criteria for immunotherapy drugs: The Lancet Oncology: March 2017

The Lancet Oncology in conversation with - A podcast by The Lancet Group

Categories:

Education

Lesley Seymour discusses the iRECIST guidelines for assessing tumour responses in immunotherapy trials. Tell us what you thought about this episode Continue this conversation on social! Follow us today at... https://twitter.com/thelancet & https://Twitter.com/TheLancetOncol https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv